Developments in the drug treatment of schizophrenia
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 13 (3), 116-121
- https://doi.org/10.1016/0165-6147(92)90041-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophreniaBiological Psychiatry, 1990
- Beyond the Dopamine HypothesisThe British Journal of Psychiatry, 1989
- No D2 Receptor Increase in PET Study of SchizophreniaArchives of General Psychiatry, 1987
- Neuroleptic-Induced Decrease in Plasma Homovanillic Acid and Antipsychotic Activity in Schizophrenic PatientsScience, 1984
- Increased concentrations and lateral asymmetry of amygdala dopamine in schizophreniaNature, 1983
- Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brainEuropean Journal of Pharmacology, 1983
- Antipsychotic Drug Action in Schizophrenic Patients: Effect on Cortical Dopamine Metabolism After Long-Term TreatmentScience, 1979
- The substituted benzamides - a novel class of dopamine antagonistsLife Sciences, 1979
- Anti-muscarinic properties of neuroleptics and drug-induced ParkinsonismNature, 1974
- Special antagonism of amphetamine-induced abnormal behaviourPsychopharmacology, 1965